Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04314089 |
|---|---|
| Brief Title: | Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902) |
| First Submitted : | March 16, 2020 |
| First Submitted that Met QC Criteria : | March 17, 2020 |
| First Posted : | March 18, 2020 |
| Last Update Submitted that Met QC Criteria : | January 18, 2024 |
| Last Update Posted : | January 19, 2024 |